The current approach to detecting potential human carcinogens relies on the rodent carcinogenicity bioassay. A set of assumptions have been set in place and an enormous data base has been accumulated.
BOOK REVIEW
International Classification of Rodent Tumors, Parts 1-5, The Rat. Editor-in-Chief, U. Mohr, IARC Scientific Publications No. 122, Lyon, France, 1992. The current approach to detecting potential human carcinogens relies on the rodent carcinogenicity bioassay. A set of assumptions have been set in place and an enormous data base has been accumulated.
While the value of rodent carcinogenicity tests continues to evoke heated debate, it is a cornerstone for regulatory agencies. I do not believe that the community of toxicologic pathologists can agree on the answer to this question: to what extent are results using high doses in rodents relevant to the situation where humans are exposed to low levels of drugs, food chemicals, and pollutants? Given the need for accuracy in diagnosis of rodent tumors, a standardized nomenclature for the lesions observed in these carcinogenicity tests is essential. This may reduce the traditional interpathologist variability in diagnosis that is a source of confusion for regulatory agencies.
Professor Mohr has been able to bring together a number of pathologists from academia and industry, from many countries, to arrive at a consensus on the descriptions of all tumor types and preneoplastic lesions. The purpose of this effort is to improve the quality of regulatory decision-making with respect to human exposure to toxic substances. A major goal of this approach is to harmonize and standardize the nomenclature and diagnostic criteria to be used worldwide. The complete range of organ systems in the rat will be covered in 10 fascicles.
The following have been reviewed: 1) Respiratory System (57 pages); 2) Soft Tissue and Musculoskeletal System (62 pages); 3) Urinary System (46 pages); 4) Hematopoietic System (27 pages); 5) Integumentary System (45 pages).
These 5 fascicles all follow the same format making them extremely easy to use. The descriptions of the diagnostic features of a specific lesion are limited to the main or essential histopathological features in the form of a concise list. Most lesions are documented with at least 1 microphotograph selected from among both spontaneous or induced lesions. A very short &dquo;differential diagnosis&dquo; section includes only the main diagnostic criteria used in distinguishing lesions.
The microphotographs are all in black and white. While they are of uniform high quality, I would have preferred color in order to link the real world. Perhaps, this can be addressed in future editions. These fascicles are user friendly and lend themselves to an &dquo;electronic&dquo; version. In fact, this project is in progress with an extensive range of color illustrations that will increase the speed and facility of access to the data required for accurate diagnosis.
A project like this usually has an interesting history. The general outline of this classification system was prepared by pathologists in chemical and pharmaceutical companies from Germany and Switzerland and at the Fraunhofer Institute of Toxicology and Aerosol Research in Hannover, Germany. It was an attempt to define nomenclature and diagnostic criteria for use in the Registry of Industrial Toxicology Animal Data (RITA). This data base, created in 1988, represented spontaneously occurring tumors and preneoplastic lesions noted in control rats from carcinogenicity and chronic toxicity studies. A continuously expanding data base, it contains information from thousands of control rats.
Clearly, a central data base, with the findings from different laboratories and different pathologists was needed to be able to compare and evaluate the results reliably. To accomplish this goal, a systematized nomenclature with sharply defined diagnostic criteria was required. In the late 1980s, the Society of Toxicologic Pathologists (USA) started an initiative to standardize diagnostic criteria of neoplastic and preneoplastic lesions in the rat. Similar activities are in progress in Japan. To harmonize these different approaches, IARC brought together scientists from many countries to generate this series of publications. This effort should be enthusiastically supported. The careful approach and quality assurance of the project will serve to elevate the evaluation of toxicologic pathology diagnoses by regulatory agencies. I recommend these practical monographs to all practicing toxicologic pathologists. BERNARD M. WAGNER, M. D. Bernard M. Wagner and Associates, Inc. Millburn, NJ 07041
